07.12.2010 • News

Uta Kemmerich-Keil: Merck KGaA to Refrain From Big Deals For Now

Uta Kemmerich-Keil is the head of Mercks corporate finance — Uta Kemmerich-Keil is the head of Merck's corporate finance

German drugmaker Merck KGaA will take a breather from pursuing larger takeover deals as it integrates its latest acquisition Millipore, a company executive said on Tuesday.

"You will not see us involved in transactions of (Millipore's) size in the short term," the company's head of corporate finance, Uta Kemmerich-Keil, said at an event, adding that management's focus was on integrating the laboratory equipment supplier.

Merck agreed to buy U.S. biotech tool maker Millipore for $6 billion in cash in February to diversify away from its pharmaceuticals business.

Company

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Virtual Event

Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.